Borrowings

3 Months Ended

Mar. 31, 2025

Debt Disclosure [Abstract]

Borrowings

10. Borrowings

Borrowings consist of the following:

	March 31, 2025		December 31, 2024
Short-term
Current portion of long-term debt	$	399,579	$	399,411
Other	683		645
Short-term borrowings and current portion of long-term debt	$	400,262	$	400,056

			Carrying amount (1)
	Principal		March 31, 2025		December 31, 2024
Long-term
3.15% 10-year notes due November 15, 2025	$	400,000	$	399,579	$	399,411
1.25% 10-year notes due November 9, 2026 (euro-denominated)	€	600,000	645,730		622,313
0.750% 8-year notes due November 4, 2027 (euro-denominated)	€	500,000	537,351		517,863
6.65% 30-year debentures due June 1, 2028	$	200,000	199,682		199,657
2.950% 10-year notes due November 4, 2029	$	300,000	298,260		298,166
5.375% 30-year debentures due October 15, 2035	$	300,000	297,370		297,308
6.60% 30-year notes due March 15, 2038	$	250,000	248,534		248,505
5.375% 30-year notes due March 1, 2041	$	350,000	345,603		345,534
Other			10		—
Total long-term debt			2,972,119		2,928,757
Less long-term debt current portion			(399,579)		(399,411)
Net long-term debt			$	2,572,540	$	2,529,346

(1) Carrying amount is net of unamortized debt discount and deferred debt issuance costs. Total unamortized debt discounts were $8.2 million and $8.5 million as of March 31, 2025 and December 31, 2024, respectively. Total deferred debt issuance costs were $6.4 million and $6.8 million as of March 31, 2025 and December 31, 2024, respectively.

The discounts are being amortized to interest expense using the effective interest method over the life of the issuances. The deferred issuance costs are amortized on a straight-line basis over the life of the debt, as this approximates the effective interest method.

On April 6, 2023, the Company entered into a $1.0 billion five-year unsecured revolving credit facility and on April 3, 2025, the Company entered into a new $500.0 million 364-day unsecured revolving credit facility (together, the "Credit Agreements") with a syndicate of banks. The current 364-day credit facility replaced the previous $500.0 million 364-day credit facility, which expired on April 3, 2025. The lenders' commitments under the Credit Agreements will terminate and any outstanding loans under the Credit Agreements will mature on April 6, 2028 and April 2, 2026, respectively. The Company may elect to extend the maturity date of any loans under the new 364-day credit facility until April 2, 2027, subject to conditions specified therein. The Credit Agreements are designated as a liquidity back-stop for the Company's commercial paper program and also are available for general corporate purposes. At the Company's election, loans under the Credit Agreements will bear interest at a base rate plus an applicable margin. The Credit Agreements require the Company to pay facility fees and impose various restrictions on the Company such as, among other things, a requirement to maintain a minimum interest coverage ratio of consolidated EBITDA to consolidated net interest expense of not less than 3.0 to 1. As of March 31, 2025 and December 31, 2024, there were no outstanding borrowings under the five-year or previous 364-day credit facilities.

The Company was in compliance with all covenants in the Credit Agreements and other long-term debt covenants at March 31, 2025 and had an interest coverage ratio of consolidated EBITDA to consolidated net interest expense of 49.4 to 1.

Letters of Credit and other Guarantees

As of March 31, 2025, the Company had approximately $170.0 million outstanding in letters of credit, surety bonds, and performance and other guarantees which primarily expire on various dates through 2035. These letters of credit and bonds are primarily issued as security for insurance, warranty and other performance obligations. In general, we would only be liable for the amount of these guarantees in the event of default in the performance of our obligations, the probability of which is believed to be remote.